STOCK TITAN
  1. Home
  2. Sec-filings
  3. QDEL
  4. [8-K] QuidelOrtho Corp Reports Material Event

QuidelOrtho (QDEL) shareholders approve board slate, say-on-pay and KPMG

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

QuidelOrtho Corporation reported the results of its 2026 Annual Meeting of Stockholders held on June 16, 2026. Stockholders elected all ten director nominees, each receiving over 56 million votes in favor, with several receiving more than 56.6 million votes for and relatively few votes withheld.

Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers, with 55,716,067 votes for, 1,486,910 against, and 22,228 abstentions, alongside 7,088,721 broker non-votes. In addition, they ratified the appointment of KPMG LLP as independent registered public accounting firm for the 2026 fiscal year, with 64,197,113 votes for, 97,367 against, and 19,446 abstentions.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Say-on-pay votes for 55,716,067 votes Advisory approval of named executive officer compensation
Say-on-pay votes against 1,486,910 votes Advisory compensation proposal opposition level
Auditor ratification votes for 64,197,113 votes Ratification of KPMG LLP for 2026 fiscal year
Auditor ratification votes against 97,367 votes Opposition to KPMG LLP ratification
Broker non-votes on director items 7,088,721 votes Non-voting broker-held shares on each director election
Votes for director Brian J. Blaser 56,664,418 votes Director election at 2026 Annual Meeting
broker non-votes financial
"Broker Non-Votes Brian J. Blaser | | 56,664,418 | | 560,787 | | 7,088,721"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory basis financial
"stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers"
independent registered public accounting firm financial
"ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s 2026 fiscal year"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Annual Meeting of Stockholders financial
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The following are the final voting results"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What did QuidelOrtho (QDEL) stockholders vote on at the 2026 Annual Meeting?
Stockholders voted on electing ten directors, approving executive compensation on an advisory basis, and ratifying KPMG LLP as independent registered public accounting firm for the 2026 fiscal year. All three proposals received majority support.

Were all QuidelOrtho (QDEL) director nominees elected at the 2026 Annual Meeting?
Yes, all ten director nominees were elected. Each nominee received over 56 million votes for, with comparatively small numbers of votes withheld and 7,088,721 broker non-votes recorded on each director election item.

How did QuidelOrtho (QDEL) stockholders vote on executive compensation in 2026?
Stockholders approved the compensation of QuidelOrtho’s named executive officers on an advisory basis, with 55,716,067 votes for, 1,486,910 against, 22,228 abstentions, and 7,088,721 broker non-votes, indicating broad but not unanimous support.

Which auditor did QuidelOrtho (QDEL) stockholders ratify for fiscal 2026?
Stockholders ratified KPMG LLP as QuidelOrtho’s independent registered public accounting firm for the 2026 fiscal year, with 64,197,113 votes for, 97,367 against, and 19,446 abstentions, reflecting strong approval of the auditor selection.

What are broker non-votes in the QuidelOrtho (QDEL) 2026 meeting results?
Broker non-votes occur when brokers hold shares for clients but do not receive voting instructions on non-routine items. For QuidelOrtho’s 2026 director and executive compensation proposals, 7,088,721 broker non-votes were recorded on each such item.
QuidelOrtho Corp false 0001906324 0001906324 2026-06-16 2026-06-16
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 16, 2026

 

 

QUIDELORTHO CORPORATION

(Exact name of Registrant as specified in its Charter)

 

 

 

Delaware   001-41409   87-4496285

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

9975 Summers Ridge Road, San Diego, California 92121

(Address of principal executive offices, including zip code)

(858) 552-1100

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, $0.001 Par Value   QDEL   The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 5.07

Submission of Matters to a Vote of Security Holders.

On June 16, 2026, QuidelOrtho Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The following are the final voting results on proposals considered and voted upon at the Annual Meeting, all of which are described in the proxy statement for the Annual Meeting, as filed with the U.S. Securities and Exchange Commission on April 27, 2026.

Proposal No. 1

The Company’s stockholders elected the ten director nominees to the Company’s Board of Directors by the votes set forth in the table below:

 

Name   Votes For   Votes Withheld   Broker Non-Votes

Brian J. Blaser

   56,664,418   560,787   7,088,721

Kenneth F. Buechler, Ph.D.

   56,008,344   1,216,861   7,088,721

John R. Chiminski

   56,788,541   436,664   7,088,721

Evelyn S. Dilsaver

   56,676,148   549,057   7,088,721

R. Scott Huennekens

   56,634,433   590,772   7,088,721

Edward L. Michael

   56,585,483   639,722   7,088,721

Mary Lake Polan, M.D., Ph.D., M.P.H.

   56,148,684   1,076,521   7,088,721

Ann D. Rhoads

   56,741,863   483,342   7,088,721

Kenneth J. Widder, M.D.

   56,078,638   1,146,567   7,088,721

Joseph D. Wilkins Jr.

   56,587,197   638,008   7,088,721

Proposal No. 2

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below:

 

Votes For   Votes Against   Abstentions   Broker Non-Votes
55,716,067   1,486,910   22,228   7,088,721

Proposal No. 3

The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s 2026 fiscal year by the votes set forth in the table below:

 

Votes For   Votes Against   Abstentions
64,197,113   97,367   19,446

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 16, 2026

 

QUIDELORTHO CORPORATION
By:  

/s/ Nathaniel B. Sisitsky

Name:   Nathaniel B. Sisitsky
Its:   Chief Legal Officer and Corporate Secretary

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents